Windlas Biotech (NSE:WINDLAS) Cash Flow for Dividends: ₹0 Mil (TTM As of Mar. 2026)


NSE:WINDLAS Windlas Biotech Ltd NSE:WINDLAS
86 GF Score
Price ₹859.00
GF Value ₹936.98
Valuation Fairly Valued
! 1 Warning Sign
View Full Analysis

What is Windlas Biotech Cash Flow for Dividends?

Windlas Biotech NSE:WINDLAS -0.56% 86 Cash Flow for Dividends is ₹0 Mil as of Mar. 2026. GuruFocus rates NSE:WINDLAS with a GF Score™ of 86/100 and a GF Value™ of ₹936.98 (Fairly Valued). The stock has 1 warning sign investors should review.

Windlas Biotech's cash flow for dividends for the three months ended in Mar. 2026 was ₹0 Mil. Its cash flow for dividends for the trailing twelve months (TTM) ended in Mar. 2026 was ₹0 Mil.

Note: A negative number here means the payment of dividends. When pays more dividends, the absolute value gets bigger.

Windlas Biotech's annual payment of dividends increased from Mar. 2024 (₹-83 Mil) to Mar. 2025 (₹-115 Mil) and increased from Mar. 2025 (₹-115 Mil) to Mar. 2026 (₹-122 Mil).

Windlas Biotech Cash Flow for Dividends Related Terms

Windlas Biotech Cash Flow for Dividends Historical Data

* Premium members only.

The historical data trend for Windlas Biotech's Cash Flow for Dividends can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Windlas Biotech Cash Flow for Dividends Chart

Windlas Biotech Annual Data
Trend Mar19 Mar20 Mar21 Mar22 Mar23 Mar24 Mar25 Mar26
Cash Flow for Dividends
Get a 7-Day Free Trial 0.00 -76.28 -83.01 -114.95 -121.56

Windlas Biotech Quarterly Data
Jun21 Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23 Dec23 Mar24 Jun24 Sep24 Dec24 Mar25 Jun25 Sep25 Dec25 Mar26
Cash Flow for Dividends Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 0.00 0.00 0.00 0.00 0.00
NSE:WINDLAS
86GF Score
Windlas Biotech Ltd NSE:WINDLAS
Cash Flow for Dividends is just one metric. See GF Score™, valuation, warning signs, and more.
View Full Analysis

Windlas Biotech Cash Flow for Dividends Calculation

Cash flow for dividends refers to the payment of cash to shareholders as dividends when the company generates income.

Cash Flow for Dividends for the trailing twelve months (TTM) ended in Mar. 2026 adds up the quarterly data reported by the company within the most recent 12 months, which was ₹0 Mil.

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

What does a Cash Flow for Dividends of ₹0 Mil mean?
Windlas Biotech (NSE:WINDLAS) has a Cash Flow for Dividends of ₹0 Mil as of Mar. 2026. Cash Flow for Dividends represent the amount a company pays as dividends for a specific accounting period. View historical data for Windlas Biotech and its competitors.
Is Windlas Biotech's Cash Flow for Dividends too high?
Windlas Biotech's current Cash Flow for Dividends is ₹0 Mil. Overall, Windlas Biotech has a GF Score™ of 86/100 and is considered Fairly Valued, reflecting its overall financial health beyond just this single metric.
How does Windlas Biotech's Cash Flow for Dividends compare to ZTS?
Windlas Biotech's Cash Flow for Dividends of ₹0 Mil can be compared against companies in the Drug Manufacturers industry. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good Cash Flow for Dividends for a Drug Manufacturers company?
A good Cash Flow for Dividends depends on the Drug Manufacturers industry context. However, Cash Flow for Dividends should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high Cash Flow for Dividends mean?
A high Cash Flow for Dividends can signal that a stock is expensive relative to its fundamentals. Cash Flow for Dividends represent the amount a company pays as dividends for a specific accounting period. View historical data for Windlas Biotech and its competitors. Windlas Biotech's current Cash Flow for Dividends is ₹0 Mil. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Windlas Biotech stock overvalued right now?
Based on GuruFocus' analysis, Windlas Biotech (NSE:WINDLAS) is currently considered Fairly Valued. The stock's GF Value™ is ₹936.98, compared to a current price of ₹859.00 — trading 8.3% below its estimated fair value. The current Cash Flow for Dividends is ₹0 Mil. Windlas Biotech's overall GF Score™ is 86/100 with 1 warning sign to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is Cash Flow for Dividends calculated?
Cash Flow for Dividends is calculated from a company's financial statements. For Windlas Biotech (NSE:WINDLAS), the current Cash Flow for Dividends is ₹0 Mil as of Mar. 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.

Is Windlas Biotech (NSE:WINDLAS) Overvalued in 2026?

Based on GuruFocus' analysis, Windlas Biotech stock appears to be undervalued. The current stock price of ₹859.00 is trading 8.3% below its estimated GF Value™ of ₹936.98. GuruFocus considers Windlas Biotech to be Fairly Valued.

Key valuation signals for NSE:WINDLAS:

  • Cash Flow for Dividends: ₹0 Mil
  • GF Value™: ₹936.98 vs. price of ₹859.00 (8.3% below fair value)
  • GF Score™: 86/100 with 1 warning sign

No single metric tells the full story. See the NSE:WINDLAS stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.

Windlas Biotech Business Description

Other Exchanges 543329:India
Address Golf Course Extension Road, 705-706, Vatika Professional Point, Sector-66, Gurgaon, HR, IND, 122 001
Windlas Biotech Ltd is a pharmaceutical formulation contract development and manufacturing organization. The company offers a range of CDMO services from product discovery to product development, licensing, and commercial manufacturing of generic products including complex generics.
86GF Score

Get the complete analysis for NSE:WINDLAS

Cash Flow for Dividends is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.

₹859.00
Price
₹936.98
GF Value